← Leaderboards
Shruthi Naik
Mayo Clinic Rochester
$1,310,428
Attributed
$2,620,855
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $828.3K · FY2022–25$1M$750K$500K$250K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$2,620,855 · 1
By mechanism
U01$2,620,855 · 1
Top collaborators
- Jaime F Modiano7 shared
Most similar at Mayo Clinic Rochester
Same institution · by research overlap
- Richard G Vile$15,977,609
- Amy C Degnim$9,208,153
- Kah-Whye Peng$11,311,466
- Paul D. Robbins$18,718,334
- Jennifer Louise Whitwell$16,907,629
Others in their field
Other Rising Stars on “S Lymphoma”
- David G Brooks · Boston Immune Technologies And Therapeutics, Inc.$3,974,764
- Arthur P Bertolino · Cytoagents, Inc.$3,313,557
- Saad J. Kenderian · Mayo Clinic Rochester$2,679,817
- Erin Marcotte · University Of Minnesota$2,501,446
- Nadine Norton · Mayo Clinic Jacksonville$2,431,858
- Caroline Uhler · Broad Institute, Inc.$2,298,000
Research focus
S LymphomaImmunosuppressionArchitectureImmuneImmune Checkpoint InhibitorImmunooncologyEngineeringHeterogeneityDiagnosisChemotherapy-Oncologic ProcedureAnti-Tumor Immune ResponseClinical DevelopmentClinically ActionableImmunogenicHodgkin DiseaseCombined Modality TherapyCanis FamiliarisGenomicsAntigen PresentationComparativeCorrelative StudyCytolysisClinicImmune Checkpoint Blockade
Grant awards (7)
Translation of a novel combination therapy approach for non-Hodgkin lymphoma$460,749
U01 · FY2025 · CA · contact PI
Translation of a novel combination therapy approach for non-Hodgkin lymphoma$121,055
U01 · FY2025 · CA · contact PI
Translation of a novel combination therapy approach for non-Hodgkin lymphoma$643,654
U01 · FY2024 · CA · contact PI
Translation of a novel combination therapy approach for non-Hodgkin lymphoma$114,223
U01 · FY2024 · CA · contact PI
Translation of a novel combination therapy approach for non-Hodgkin lymphoma$70,432
U01 · FY2024 · CA · contact PI
Translation of a novel combination therapy approach for non-Hodgkin lymphoma$625,851
U01 · FY2023 · CA · contact PI
Translation of a novel combination therapy approach for non-Hodgkin lymphoma$584,891
U01 · FY2022 · CA · contact PI